These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Variations of properdin in cancer patients]. MARQUES P; DOUSTE-BLAZY L; LLOVERAS J; PUEL J Bull Assoc Fr Etud Cancer; 1960; 47():479-87. PubMed ID: 13767080 [No Abstract] [Full Text] [Related]
3. [The properdin level in neoplasms and in malignant blood diseases]. DIOMEDE-FRESA V; FUMAROLA A Prog Med (Napoli); 1959 May; 15():310-4. PubMed ID: 13816890 [No Abstract] [Full Text] [Related]
4. Levels of properdin in patients with carcinoma. MYERBURG RJ Am J Clin Pathol; 1959 May; 31(5):415-8. PubMed ID: 13649635 [No Abstract] [Full Text] [Related]
5. Serum properdin levels and cancer cell homografts in man. SOUTHAM CM; PILLEMER L Proc Soc Exp Biol Med; 1957 Dec; 96(3):596-601. PubMed ID: 13505801 [No Abstract] [Full Text] [Related]
6. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan]. SZABO IK Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258 [No Abstract] [Full Text] [Related]
7. A study of the serum properdin levels of patients with malignant tumors. ROTTINO A; LEVY AL; CONTE A Cancer; 1958; 11(2):351-6. PubMed ID: 13511356 [No Abstract] [Full Text] [Related]
8. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan]. FUMAROLA D; MODICA F Tumori; 1959; 45(1):46-53. PubMed ID: 13659609 [No Abstract] [Full Text] [Related]
9. [Relation between zymosan, properdin & tumors. 2. Behavior of properdin level in rats with benzpyrene-induced sarcomas]. MODICA F; FUMAROLA D Tumori; 1958; 44(6):549-54. PubMed ID: 13635873 [No Abstract] [Full Text] [Related]
10. Serum-properdin levels in patients with Hodgkin's disease and carcinoma. ROTTINO A; LEVY AL Cancer; 1957; 10(5):877-83. PubMed ID: 13472632 [No Abstract] [Full Text] [Related]
11. [Interrelations of zymosan, properdin & tumors. IV. Behavior of mucopolysaccharides in the blood in benzopyrene sarcoma-bearing rats]. MODICA F Tumori; 1959; 45(1):54-9. PubMed ID: 13659610 [No Abstract] [Full Text] [Related]
12. Bactericidal effect of serum from normal chickens and chickens with Rous sarcoma. HERNBERG S Ann Med Exp Biol Fenn; 1961; 39():251-8. PubMed ID: 13906763 [No Abstract] [Full Text] [Related]
13. Comparison of properdin levels in general medical and hematologic patients. CARLISLE HN; SASLAW S Am J Med Sci; 1961 Sep; 242():271-8. PubMed ID: 13690813 [No Abstract] [Full Text] [Related]
14. CANCER cells in the blood. Lancet; 1959 Jan; 1(7066):240. PubMed ID: 13631984 [No Abstract] [Full Text] [Related]
15. Cancer cells in the circulating blood. ROBERTS SS; COLE WH Semin Int; 1961; 10():2-10. PubMed ID: 13742184 [No Abstract] [Full Text] [Related]
16. The significance of cancer cells in the blood. MOORE GE Surg Gynecol Obstet; 1960 Mar; 110():360-1. PubMed ID: 14423856 [No Abstract] [Full Text] [Related]
17. The blood chemical changes in cancer; a review. LARSON JA; JOHNSON W Q Bull Northwest Univ Med Sch; 1952; 26(1):36-43. PubMed ID: 14912262 [No Abstract] [Full Text] [Related]
18. [The proteinemia, often paradoxical, in the blood or cancer patients]. LOEPER M Prog Med (Paris); 1952 Dec; 80(24):587-8. PubMed ID: 13027423 [No Abstract] [Full Text] [Related]
19. [Research on cancer cells in the circulating blood]. FRIDEN-KILL L; MINDER WH Schweiz Med Wochenschr; 1962 Jul; 92():915-8. PubMed ID: 13895158 [No Abstract] [Full Text] [Related]
20. [Examination of toxins in the blood in cancer]. VENULET F; MOSKWA W Schweiz Med Wochenschr; 1952 Jan; 82(3):55-7. PubMed ID: 14913122 [No Abstract] [Full Text] [Related] [Next] [New Search]